035610.KQ Solborn Inc
- Market cap
- KRW 135B
- P/E
- 3.8x
- P/B
- 0.56x
- ROE
- 21.3%
- Dividend yield
- 0.92%
- Fundamental score
- 2.7/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 035610.KQ undervalued?
Graham numberThe Graham number of Solborn Inc cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Solborn Inc fundamental analysis
14 of 22 checks passedROE 2/2
High return on equity (21.3%), above 20%.
ROA 1/1
Return on assets (11.9%) is above the industry median (6.2%).
Profit Consistency 1/2
Profitable for 3 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Last year's EPS growth (-46.9%) is not above the 5-year average (68.4% a year).
Earnings Growth vs Industry 0/1
Last year's EPS growth (-46.9%) is below the industry median (0.5%).
Revenue Growth 1/2
Revenue grew 8.7% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 0/1
Debt is not reported.
Interest Coverage 1/1
EBIT is 1,130.7x against interest expense, well covered.
PE vs Market 1/1
PE (3.8x) is below the market median (11.3x).
PE vs Industry 1/1
PE (3.8x) is below the industry median (7.6x).
PBV 1/1
Price to book (0.6x) is below the industry median (0.7x).
Graham Number 1/1
The price is below the Graham number (PE x PB = 2.1, limit 22.5).
PEG 1/1
PEG on 5-year earnings growth is 0.06, growth is cheap.
Dividend Yield 0/2
Dividend yield (0.9%) is in the bottom 25% of dividend payers in the market.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 1/1
Payout ratio is 6.0%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Solborn Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Solborn Inc
Solborn, Inc., an investment holding company, engages in the manufacturing and sales of medical equipment in South Korea. The company engages in the PACS and S/W manufacturing, sales, and maintenance; medical device H/W manufacturing, wholesale, and maintenance. It is also involved in provision of newspaper issuance and online information services. In addition, the company invests in small and medium-sized enterprises and venture companies. Further, it engages in golf relate…
Full company profileSolborn Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Solborn Inc annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 74.5B | 74.1B | 84.4B | 80.3B | 82.0B | 100B | 93.8B | 120B | 122B | 121B | 141B |
| Gross Profit | 41.9B | 40.1B | 54.5B | 42.5B | 45.0B | 55.8B | 22.9B | 80.9B | 81.6B | 79.7B | 94.4B |
| Operating Income | 5.87B | 2.26B | 11.5B | 2.82B | 8.76B | 15.7B | -26.8B | 33.9B | 26.1B | 24.6B | 39.5B |
| EBITDA | - | - | - | - | - | - | -42.5B | 55.2B | 67.2B | 49.3B | 111B |
| Net Income | 387M | -5.64B | 9.93B | 1.78B | 1.45B | 17.8B | -41.7B | 38.2B | 36.9B | 20.9B | 51.5B |
| EPS | 15 | -220 | 387 | 69 | 56 | 694 | -1,625 | 1,490 | 1,438 | 763 | 1,882 |
| Balance Sheet | |||||||||||
| Total Assets | 191B | 187B | 197B | 208B | 218B | 256B | 221B | 276B | 351B | 375B | 431B |
| Total Liabilities | 62.5B | 59.9B | 58.5B | 67.9B | 79.1B | 94.5B | 96.8B | 111B | 145B | 62.6B | 72.8B |
| Shareholders' Equity | 129B | 128B | 139B | 140B | 139B | 162B | 124B | 165B | 207B | 213B | 242B |
| Cash & Short-term Investments | 52.5B | 54.4B | 80.3B | 65.4B | 73.3B | 87.4B | 82.9B | 108B | 158B | 22.7B | 20.0B |
| Total Debt | - | - | - | 2.93B | 2.56B | - | - | - | - | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 1.33B | 3.85B | 5.71B | 13.7B | 17.8B | 15.8B | 14.8B | 11.2B | 15.3B | 15.1B | 19.0B |
| Capital Expenditure | 2.15B | 1.06B | 439M | 1.65B | 1.20B | 804M | 476M | 720M | 427M | 528M | 325M |
| Free Cash Flow | - | - | - | - | 16.4B | 14.6B | 14.3B | 10.5B | 14.9B | 14.5B | 18.7B |
| Ratios | |||||||||||
| ROE | 0.3% | -4.4% | 7.2% | 1.3% | 1.0% | 11.0% | -33.7% | 23.2% | 17.9% | 9.8% | 21.3% |
| ROA | 0.2% | -3.0% | 5.0% | 0.9% | 0.7% | 7.0% | -18.9% | 13.9% | 10.5% | 5.6% | 11.9% |
| Net Profit Margin | 0.5% | -7.6% | 11.8% | 2.2% | 1.8% | 17.8% | -44.5% | 31.9% | 30.3% | 17.3% | 36.6% |
| Debt to Equity | - | - | - | 0.02x | 0.02x | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Solborn Inc dividends
- Dividend yield
- 0.92%
- Forward dividend
- -
- Payout ratio
- 6.0%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | KRW 1.25B | 46 | 6.0% |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 9997:13329 on Jul 4, 2005.
Who owns Solborn Inc
- Insiders 64.98%
- Institutions 0.00%
- Public & others 35.02%
- Shares outstanding 27.3M
- Free float 279K
Solborn Inc company profile
- Company name
- Solborn Inc
- Ticker
- 035610.KQ
- ISIN
- KR7035610005
- Exchange
- KOSDAQ
- Sector
- Industrials
- Industry
- Health Care Equipment & Supplies
- Employees
- 10
- Fiscal year end
- December
- Address
- 66-4, Cheongdam-dong, Seoul, South Korea
- Phone
- 82 2 580 2800
- Website
- solborn.co.kr
About Solborn Inc
Solborn, Inc., an investment holding company, engages in the manufacturing and sales of medical equipment in South Korea. The company engages in the PACS and S/W manufacturing, sales, and maintenance; medical device H/W manufacturing, wholesale, and maintenance. It is also involved in provision of newspaper issuance and online information services. In addition, the company invests in small and medium-sized enterprises and venture companies. Further, it engages in golf related business and real estate leasing business. The company was formerly known as Serome Technology, Inc. Solborn, Inc. was founded in 1994 and is headquartered in Seoul, South Korea.
Solborn Inc management
3- Mr. Gi-Tae HongChairman & CEO · born 1957
- Mr. Hae-Gu YuDirector of Business Administration Division · born 1968
- Ms. Hye-Suk LeeVP & Director · born 1965